http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2009597-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5712b4838bdb16ebbc41121239e165b9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-08
filingDate 1978-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1979-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2009597-A
titleOfInvention Gelled Antacid Dosage Units
abstract A method of preparing gelled oral antacid dosage units having fudge or jelly consistency by gelling a dispersion of antacid in water containing carbohydrate or polyhydric alcohol bodying agent, and forming dosage units preferably in moulds from the gelled dispersion. Gelling agents include gelatin, agar, food starch and calcium alginate. Moulds can be formed in final packaging material, such as metal foil. The bodying agent may be sucrose, a mixture of sucrose and glucose, sorbitol or mannitol.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5466464-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4656028-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0432956-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0009913-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4609543-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0009913-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-594148-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4581381-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4937076-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1926475-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0651997-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5322694-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1238663-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0460588-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4533543-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0243930-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0122463-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5629003-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1238663-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1926475-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008017337-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0651997-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-634609-B2
priorityDate 1977-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452841941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24836924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160967529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988

Total number of triples: 59.